These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9811937

  • 21. A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy.
    Lefebvre S, Burlet P, Viollet L, Bertrandy S, Huber C, Belser C, Munnich A.
    Hum Mol Genet; 2002 May 01; 11(9):1017-27. PubMed ID: 11978761
    [Abstract] [Full Text] [Related]

  • 22. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.
    Liu Q, Fischer U, Wang F, Dreyfuss G.
    Cell; 1997 Sep 19; 90(6):1013-21. PubMed ID: 9323129
    [Abstract] [Full Text] [Related]

  • 23. Cell-specific survival motor neuron gene expression during human development of the central nervous system: implications for the pathogenesis of spinal muscular atrophy.
    Tizzano EF, Cabot C, Baiget M.
    Am J Pathol; 1998 Aug 19; 153(2):355-61. PubMed ID: 9708795
    [Abstract] [Full Text] [Related]

  • 24. Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy.
    Beattie CE, Carrel TL, McWhorter ML.
    J Child Neurol; 2007 Aug 19; 22(8):995-1003. PubMed ID: 17761655
    [Abstract] [Full Text] [Related]

  • 25. Treatment of spinal muscular atrophy by sodium butyrate.
    Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H.
    Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9808-13. PubMed ID: 11504946
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord.
    Pagliardini S, Giavazzi A, Setola V, Lizier C, Di Luca M, DeBiasi S, Battaglia G.
    Hum Mol Genet; 2000 Jan 01; 9(1):47-56. PubMed ID: 10587577
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Identification of survival motor neuron as a transcriptional activator-binding protein.
    Strasswimmer J, Lorson CL, Breiding DE, Chen JJ, Le T, Burghes AH, Androphy EJ.
    Hum Mol Genet; 1999 Jul 01; 8(7):1219-26. PubMed ID: 10369867
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells.
    Young PJ, Le TT, thi Man N, Burghes AH, Morris GE.
    Exp Cell Res; 2000 May 01; 256(2):365-74. PubMed ID: 10772809
    [Abstract] [Full Text] [Related]

  • 35. A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neurons.
    Francis JW, Figueiredo D, vanderSpek JC, Ayala LM, Kim YS, Remington MP, Young PJ, Lorson CL, Ikebe S, Fishman PS, Brown RH.
    Brain Res; 2004 Jan 02; 995(1):84-96. PubMed ID: 14644474
    [Abstract] [Full Text] [Related]

  • 36. SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis.
    Patrizi AL, Tiziano F, Zappata S, Donati MA, Neri G, Brahe C.
    Eur J Hum Genet; 1999 Apr 02; 7(3):301-9. PubMed ID: 10234506
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Development of a gene therapy strategy for the restoration of survival motor neuron protein expression: implications for spinal muscular atrophy therapy.
    DiDonato CJ, Parks RJ, Kothary R.
    Hum Gene Ther; 2003 Jan 20; 14(2):179-88. PubMed ID: 12614569
    [Abstract] [Full Text] [Related]

  • 40. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT, Chen CS, Jong YJ, Chang FR, Lo YC.
    Pharmacol Res; 2016 Sep 20; 111():58-75. PubMed ID: 27241020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.